For asymptomatic people without known risks, the downsides and uncertainties of multi-cancer early detection testing could ...

Personalis, Inc. PSNL stock is up in Tuesday’s premarket session after the company received Medicare coverage for its NeXT Personal molecular residual disease test for lung cancer surveillance. This ...

After the government announced on the 24th a plan to raise the early diagnosis rate of the six major cancers—stomach, breast, cervical, liver, colorectal, and lung cancers—to 60% by 2030, medical ...

Personalis shares rose after the company received Medicare coverage for its NeXT Personal molecular residual disease test for surveillance of patients with Stage I to III non-small cell lung cancer.

Lung cancer coverage, supported by data from the landmark TRACERx collaboration, follows recent approval in breast cancer, providing access to Medicare patients. FREMONT, Calif.--(BUSINESS WIRE)-- ...

A new national survey has revealed alarming gaps in women’s awareness of free screenings and Medicare rebates. From Medicare-rebated menopause assessments to self-collected cervical screening and ...

If you get sick or injured and need hospital care, which can cost thousands of dollars, would you be able to afford it? Research published in the Annals of Internal Medicine suggests it may be a ...

Coverage of high-cost drugs selected for Medicare price negotiation has improved under the Inflation Reduction Act, according to an analysis from KFF. All Medicare Part D enrollees now have coverage ...

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. If you watched the Super Bowl, you ...

Seniors can either stick with traditional Medicare or pick a Medicare Advantage Plan. Advantage Plans are sold by private insurers, and they may offer coverage for more services than traditional ...

MENLO PARK, Calif., Feb. 19, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial ...